Oxford Asset Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,853
Closed -$34K 874
2016
Q2
$34K Sell
1,853
-1,140
-38% -$30.3K ﹤0.01% 768
2016
Q1
$79K Sell
2,993
-7,504
-71% -$234K ﹤0.01% 757
2015
Q4
$387K Buy
10,497
+5,844
+126% +$254K 0.01% 714
2015
Q3
$154K Buy
4,653
+1,653
+55% +$93.1K ﹤0.01% 592
2015
Q2
$207K Sell
3,000
-1,748
-37% -$121K 0.01% 598
2015
Q1
$357K Buy
4,748
+576
+14% +$45.3K 0.01% 566
2014
Q4
$347K Buy
+4,172
New +$339K 0.01% 592
2013
Q3
Sell
-788
Closed -$58K 919
2013
Q2
$58K Buy
+788
New +$45.5K ﹤0.01% 839

Other funds holding ALIM

Oxford Asset Management's ALIM Position: Q3 2016 in Review

Oxford Asset Management sold out of Alimera Sciences (ALIM) in Q3 2016, closing a stake of 1,853 shares — an estimated $34K sold.

Oxford Asset Management first reported a position in ALIM in Q2 2013 and held it in 8 quarters. The position peaked at $387K in Q4 2015. 54 funds tracked by Wall St. Rank hold ALIM as of Q3 2016.

  • Oxford Asset Management reported no remaining Alimera Sciences position as of Q3 2016 after selling out during the quarter.
  • Oxford Asset Management sold 1,853 Alimera Sciences shares in Q3 2016, an estimated $34K.
  • Oxford Asset Management first reported a position in Alimera Sciences in Q2 2013 and held it in 8 quarters.
  • Oxford Asset Management's Alimera Sciences position peaked at $387K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.